IN8BIO, INC. Increase (Decrease) in Other Noncurrent Assets
IN8BIO, INC. (INAB) reported Increase (Decrease) in Other Noncurrent Assets of -$44.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- IN8BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$27.00K.
- IN8BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$17.00K.
- IN8BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$23.00K.
- IN8BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$106.00K, a 2750.00% decline year-over-year.
- IN8BIO, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$129.00K, a 745.00% decline from fiscal 2024.
- IN8BIO, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $20.00K.
- IN8BIO, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IN8BIO, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $97.00K, a 38.99% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$44.00K 10-Q · filed 2026-08-06 | -$67.00K derived: sum of 3 quarters · filed 2026-08-06 | -$173.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$17.00K 10-Q · filed 2026-05-07 | -$40.00K derived: sum of 2 quarters · filed 2026-05-07 | -$146.00K derived: sum of 3 quarters · filed 2026-05-07 | -$146.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$129.00K derived: sum of 2 quarters · filed 2026-03-12 | -$129.00K derived: sum of 3 quarters · filed 2026-08-06 | -$129.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$106.00K derived: sum of 2 quarters · filed 2026-08-06 | -$106.00K 10-Q · filed 2025-11-06 | -$155.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$49.00K derived: sum of 3 quarters · filed 2026-08-06 | -$45.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$49.00K derived: sum of 2 quarters · filed 2026-05-07 | -$45.00K derived: sum of 3 quarters · filed 2026-05-07 | -$45.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$45.00K derived: sum of 2 quarters · filed 2026-03-12 | -$45.00K derived: sum of 3 quarters · filed 2026-03-12 | $20.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.00K derived: sum of 2 quarters · filed 2025-11-06 | $69.00K 10-Q · filed 2025-11-06 | $69.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $65.00K 10-Q · filed 2025-08-07 | $65.00K derived: sum of 3 quarters · filed 2025-08-07 | $65.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $65.00K 10-Q · filed 2025-05-07 | $65.00K derived: sum of 2 quarters · filed 2025-05-07 | $65.00K derived: sum of 3 quarters · filed 2025-05-07 | $65.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $24.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $24.00K derived: sum of 3 quarters · filed 2024-08-08 | $9.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $24.00K derived: sum of 2 quarters · filed 2024-05-09 | $9.00K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $9.00K derived: sum of 2 quarters · filed 2024-03-14 | $97.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $73.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $88.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | -$109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $159.00K derived: sum of 2 quarters · filed 2023-03-30 | $159.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $268.00K 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-09-10 | |||
| 2020-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $47.00K derived: sum of 2 quarters · filed 2022-03-17 | $48.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $12.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $1.00K 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |